Lynn Anne Bristol

Array ( [id] => 8340155 [patent_doc_number] => 08242079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases' [patent_app_type] => utility [patent_app_number] => 12/964327 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12867 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12964327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212873 [patent_doc_number] => 20110136173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment' [patent_app_type] => utility [patent_app_number] => 12/961751 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12708 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136173.pdf [firstpage_image] =>[orig_patent_app_number] => 12961751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502225 [patent_doc_number] => 20110263828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHODS FOR MODIFYING HUMAN ANTIBODIES BY GLYCAN ENGINEERING' [patent_app_type] => utility [patent_app_number] => 12/959351 [patent_app_country] => US [patent_app_date] => 2010-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12366 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263828.pdf [firstpage_image] =>[orig_patent_app_number] => 12959351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935942 [patent_doc_number] => 20110212087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Antibody Fc Mutants with Ablated Effector Functions' [patent_app_type] => utility [patent_app_number] => 12/955240 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7860 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212087.pdf [firstpage_image] =>[orig_patent_app_number] => 12955240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9957415 [patent_doc_number] => 09005614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'PRLR-specific antibody and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/951744 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 47777 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12951744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140467 [patent_doc_number] => 08580928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'CDR-repaired antibodies' [patent_app_type] => utility [patent_app_number] => 12/947714 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26762 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12947714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000657 [patent_doc_number] => 20110117080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Anti-REG4 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/945588 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22135 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117080.pdf [firstpage_image] =>[orig_patent_app_number] => 12945588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6030982 [patent_doc_number] => 20110081345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'SINGLE CHAIN FC, METHODS OF MAKING AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/941194 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 53273 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081345.pdf [firstpage_image] =>[orig_patent_app_number] => 12941194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054492 [patent_doc_number] => 20110110852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Multivalent Antibodies and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 12/939117 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 89 [patent_no_of_words] => 44713 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110852.pdf [firstpage_image] =>[orig_patent_app_number] => 12939117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183740 [patent_doc_number] => 20110123523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'ANTIBODIES AGAINST ERBB3 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/904492 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 32329 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123523.pdf [firstpage_image] =>[orig_patent_app_number] => 12904492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101662 [patent_doc_number] => 20110165154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA' [patent_app_type] => utility [patent_app_number] => 12/903051 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10412 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165154.pdf [firstpage_image] =>[orig_patent_app_number] => 12903051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055916 [patent_doc_number] => 20110112276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'MUTATED IMMUNOGLOBULIN-BINDING PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/900958 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10826 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112276.pdf [firstpage_image] =>[orig_patent_app_number] => 12900958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928905 [patent_doc_number] => 20110038864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/892725 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16515 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038864.pdf [firstpage_image] =>[orig_patent_app_number] => 12892725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118559 [patent_doc_number] => 20110076232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'SPECIFIC BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/890029 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 81617 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12890029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113110 [patent_doc_number] => 08569280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Methods for the treatment of multiple myeloma' [patent_app_type] => utility [patent_app_number] => 12/888001 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6204 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12888001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555266 [patent_doc_number] => 08067167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Hybrid antibodies' [patent_app_type] => utility [patent_app_number] => 12/885303 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 46 [patent_no_of_words] => 14217 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 270 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067167.pdf [firstpage_image] =>[orig_patent_app_number] => 12885303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095368 [patent_doc_number] => 20110002942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Engineered Anti-IL-23 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/882035 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22199 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002942.pdf [firstpage_image] =>[orig_patent_app_number] => 12882035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125532 [patent_doc_number] => 20110086056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Methods for the early diagnosis of ovarian cancer' [patent_app_type] => utility [patent_app_number] => 12/807390 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15001 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086056.pdf [firstpage_image] =>[orig_patent_app_number] => 12807390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10856965 [patent_doc_number] => 08883159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Antibodies against CDCP1 for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/868849 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10527 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12868849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038406 [patent_doc_number] => 20110091455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'ANTIBODIES TO MYOSTATIN' [patent_app_type] => utility [patent_app_number] => 12/869060 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 35033 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091455.pdf [firstpage_image] =>[orig_patent_app_number] => 12869060 [rel_patent_id] =>[rel_patent_doc_number] =>)